Join the club for FREE to access the whole archive and other member benefits.

Leroy (Lee) Cronin

CEO Founder of Chemify and Regius Professor of Chemistry at the University of Glasgow

Lee Cronin was born in the UK and was fascinated with science and technology from an early age getting his first computer and chemistry set when he was 8 years old. This is when he first started thinking about programming chemistry and looking for inorganic aliens. He went to the University of York where he completed both a degree and PhD in Chemistry and then on to do post docs in Edinburgh and Germany before becoming a lecturer at the Universities of Birmingham, and then Glasgow where he has been since 2002 working up the ranks to become the Regius Professor of Chemistry in 2013 aged 39. He has one of the largest multidisciplinary chemistry-based research teams in the world, having raised over $35 M in grants and current income of $15 M. He has given over 300 international talks and has authored over 350 peer reviewed papers with recent work published in Nature, Science, and PNAS. He and his team are trying to make artificial life forms, find alien life, explore the digitization of chemistry, understand how information can be encoded into chemicals and construct chemical computers.

Visit website: http://www.chem.gla.ac.uk/cronin/members/Lee/

 leecronin

 leecronin

 UC0a0m4Xb5ZBPrVRdWPxFBKQ

See also: Academia University of Glasgow - Public research university for UK and international students

Details last updated 30-Jan-2020

Leroy (Lee) Cronin News

Robot revolutionises study of new molecules

Robot revolutionises study of new molecules

Independent - 18-Jul-2018

This software test many chemical reactions simultaneously and may lead to faster drug discovery

The Future Of Pharmaceuticals Is Custom-Printing Drugs

The Future Of Pharmaceuticals Is Custom-Printing Drugs

Gizmodo - 28-Sep-2017

New drug custom-printing method would allow pharmacists to customise for dosage, for your own per...

3D-printed pill approved by FDA

3D-printed pill approved by FDA

Guardian - 05-Aug-2015

Aprecia launches first FDA approved 3D-printed drug. The epilepsy pill could lead the way to pers...